Suïssa - alemany - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - amlodipinum, valsartanum, hydrochlorothiazidum - filmtabletten - amlodipinum 5 mg ut amlodipini besilas, valsartanum 160 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, talcum, e 171, e 172 (flavum), pro compresso obducto. - essentielle hypertonie - synthetika

Suïssa - alemany - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - amlodipinum, valsartanum, hydrochlorothiazidum - filmtabletten - amlodipinum 10 mg ut amlodipini besilas, valsartanum 160 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, talcum, e 172 (flavum), pro compresso obducto. - essentielle hypertonie - synthetika

Suïssa - alemany - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - amlodipinum, valsartanum, hydrochlorothiazidum - filmtabletten - amlodipinum 10 mg ut amlodipini besilas, valsartanum 320 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, talcum, e 172 (flavum), pro compresso obducto. - essentielle hypertonie - synthetika

Suïssa - alemany - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - amlodipinum, valsartanum, hydrochlorothiazidum - filmtabletten - amlodipinum 5 mg ut amlodipini besilas, valsartanum 160 mg, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, hydroxypropylcellulosum, silica colloidalis anhydrica, magnesii stearas, talcum, Überzug: poly(alcohol vinylicus), talcum, e 171, macrogolum 4000, acidi methacrylici copolymerum c, natrii hydrogenocarbonas corresp. natrium 0.005 mg, pro compresso obducto. - essentielle hypertonie - synthetika

Suïssa - alemany - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - amlodipinum, valsartanum, hydrochlorothiazidum - filmtabletten - amlodipinum 5 mg ut amlodipini besilas, valsartanum 160 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, hydroxypropylcellulosum, silica colloidalis anhydrica, magnesii stearas, talcum, Überzug: poly(alcohol vinylicus), talcum, e 171, macrogolum 4000, acidi methacrylici copolymerum c, natrii hydrogenocarbonas corresp. natrium 0.005 mg, e 172 (flavum), pro compresso obducto. - essentielle hypertonie - synthetika

Suïssa - alemany - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - amlodipinum, valsartanum, hydrochlorothiazidum - filmtabletten - amlodipinum 10 mg ut amlodipini besilas, valsartanum 160 mg, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, hydroxypropylcellulosum, silica colloidalis anhydrica, magnesii stearas, talcum, Überzug: poly(alcohol vinylicus), e 171, talcum, macrogolum 4000, acidi methacrylici copolymerum c, natrii hydrogenocarbonas corresp. natrium 0.005 mg, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - essentielle hypertonie - synthetika

Suïssa - alemany - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - amlodipinum, valsartanum, hydrochlorothiazidum - filmtabletten - amlodipinum 10 mg ut amlodipini besilas, valsartanum 160 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, hydroxypropylcellulosum, silica colloidalis anhydrica, magnesii stearas, talcum, Überzug: poly(alcohol vinylicus), e 171, talcum, macrogolum 4000, acidi methacrylici copolymerum c, natrii hydrogenocarbonas corresp. natrium 0.005 mg, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - essentielle hypertonie - synthetika

Suïssa - alemany - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - kapseln - levodopum 50.00 mg, benserazidum 12.50 mg ut benserazidi hydrochloridum, mannitolum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (nigrum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbus parkinson, restless-legs-syndrom - synthetika

Suïssa - alemany - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - kapseln - levodopum 100.0 mg, benserazidum 25.0 mg ut benserazidi hydrochloridum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (rubrum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbus parkinson, restless-legs-syndrom - synthetika

Suïssa - alemany - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - kapseln - levodopum 200.0 mg, benserazidum 50.0 mg ut benserazidi hydrochloridum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (rubrum), e 172 (flavum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbus parkinson, restless-legs-syndrom - synthetika